NexgenRx, Inc. (NXG) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

NexgenRx, Inc.

BQE Water, Inc.

Redishred Capital Corp.

Neptune Digital Assets Corp.

SSC Security Services Corp.

American Aires, Inc.

Personas Social, Inc.

EverGen Infrastructure Corp.

Vertex Resource Group Ltd.

TDG Gold Corp.

Base Carbon, Inc.

Why is NexgenRx, Inc. ?

High Management Efficiency with a high ROE of 17.21%

Company has a low Debt to Equity ratio (avg) at times

With a growth in Net Profit of 1007.38%, the company declared Very Positive results in Jun 25

The company has declared positive results for the last 4 consecutive quarters
PRE-TAX PROFIT(Q) At CAD 0.33 MM has Grown at 3,546.9%
NET PROFIT(Q) At CAD 0.35 MM has Grown at 1,007.38%
ROCE(HY) Highest at 12.52%

With ROE of 12.40%, it has a fair valuation with a 3.52 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 61.54%, its profits have risen by 103% ; the PEG ratio of the company is 0

Market Beating Performance

The stock has generated a return of 61.54% in the last 1 year, much higher than market (S&P/TSX 60) returns of 19.10%

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to NexgenRx, Inc. should be less than 10%
Overall Portfolio exposure to Miscellaneous should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is NexgenRx, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

NexgenRx, Inc.

61.54%

0.99

45.45%

S&P/TSX 60

20.39%

1.25

15.27%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

11.21%

EBIT Growth (5y)

7.42%

EBIT to Interest (avg)

0.73

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-3.16

Sales to Capital Employed (avg)

1.76

Tax Ratio

37.71%

Dividend Payout Ratio

169.49%

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

17.21%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.52

EV to EBIT

-0.53

EV to EBITDA

-0.26

EV to Capital Employed

0.03

EV to Sales

-0.03

PEG Ratio

0.01

Dividend Yield

ROCE (Latest)

-3.52%

ROE (Latest)

12.40%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

Bullish

Bearish

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

21What is working for the Company

PRE-TAX PROFIT(Q)

At CAD 0.33 MM has Grown at 3,546.9%

NET PROFIT(Q)

At CAD 0.35 MM has Grown at 1,007.38%

ROCE(HY)

Highest at 12.52%

DEBT-EQUITY RATIO (HY)

Lowest at -353.46 %

RAW MATERIAL COST(Y)

Fallen by -3.23% (YoY

CASH AND EQV(HY)

Highest at CAD 54.74 MM

-3What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CAD -4 MM

Here's what is working for NexgenRx, Inc.

Pre-Tax Profit

At CAD 0.33 MM has Grown at 3,546.9%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CAD MM)

Net Profit

At CAD 0.35 MM has Grown at 1,007.38%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CAD MM)

Debt-Equity Ratio

Lowest at -353.46 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Cash and Eqv

Highest at CAD 54.74 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by -3.23% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for NexgenRx, Inc.

Operating Cash Flow

Lowest at CAD -4 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CAD MM)